img

Global Biologic Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biologic Drugs Market Insights, Forecast to 2034

Global Biologic Drugs market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Biologic Drugs industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Biologic Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biologic Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Segment by Type
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others

Segment by Application


Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Biologic Drugs plant distribution, commercial date of Biologic Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Biologic Drugs introduction, etc. Biologic Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Biologic Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Biologic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Biologic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Humira
1.2.3 Remicade
1.2.4 Rituxan
1.2.5 Enbrel
1.2.6 Lantus
1.2.7 Avastin
1.2.8 Herceptin
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biologic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diabetes
1.3.3 Inflammation
1.3.4 Auto-Immune Diseases
1.3.5 Blood Diseases
1.3.6 Cardiovascular Diseases
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biologic Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Biologic Drugs Revenue by Region
2.2.1 Global Biologic Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biologic Drugs Revenue by Region (2018-2024)
2.2.3 Global Biologic Drugs Revenue by Region (2024-2029)
2.2.4 Global Biologic Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Biologic Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Biologic Drugs Sales by Region
2.4.1 Global Biologic Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biologic Drugs Sales by Region (2018-2024)
2.4.3 Global Biologic Drugs Sales by Region (2024-2029)
2.4.4 Global Biologic Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biologic Drugs Sales by Manufacturers
3.1.1 Global Biologic Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Biologic Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologic Drugs in 2022
3.2 Global Biologic Drugs Revenue by Manufacturers
3.2.1 Global Biologic Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Biologic Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Biologic Drugs Revenue in 2022
3.3 Global Key Players of Biologic Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Biologic Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biologic Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biologic Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Biologic Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biologic Drugs Sales by Type
4.1.1 Global Biologic Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Biologic Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Biologic Drugs Sales Market Share by Type (2018-2029)
4.2 Global Biologic Drugs Revenue by Type
4.2.1 Global Biologic Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Biologic Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biologic Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Biologic Drugs Price by Type
4.3.1 Global Biologic Drugs Price by Type (2018-2024)
4.3.2 Global Biologic Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biologic Drugs Sales by Application
5.1.1 Global Biologic Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Biologic Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Biologic Drugs Sales Market Share by Application (2018-2029)
5.2 Global Biologic Drugs Revenue by Application
5.2.1 Global Biologic Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Biologic Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biologic Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Biologic Drugs Price by Application
5.3.1 Global Biologic Drugs Price by Application (2018-2024)
5.3.2 Global Biologic Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biologic Drugs Market Size by Type
6.1.1 US & Canada Biologic Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Biologic Drugs Revenue by Type (2018-2029)
6.2 US & Canada Biologic Drugs Market Size by Application
6.2.1 US & Canada Biologic Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Biologic Drugs Revenue by Application (2018-2029)
6.3 US & Canada Biologic Drugs Market Size by Country
6.3.1 US & Canada Biologic Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biologic Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Biologic Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biologic Drugs Market Size by Type
7.1.1 Europe Biologic Drugs Sales by Type (2018-2029)
7.1.2 Europe Biologic Drugs Revenue by Type (2018-2029)
7.2 Europe Biologic Drugs Market Size by Application
7.2.1 Europe Biologic Drugs Sales by Application (2018-2029)
7.2.2 Europe Biologic Drugs Revenue by Application (2018-2029)
7.3 Europe Biologic Drugs Market Size by Country
7.3.1 Europe Biologic Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biologic Drugs Sales by Country (2018-2029)
7.3.3 Europe Biologic Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biologic Drugs Market Size
8.1.1 China Biologic Drugs Sales (2018-2029)
8.1.2 China Biologic Drugs Revenue (2018-2029)
8.2 China Biologic Drugs Market Size by Application
8.2.1 China Biologic Drugs Sales by Application (2018-2029)
8.2.2 China Biologic Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biologic Drugs Market Size by Type
9.1.1 Asia Biologic Drugs Sales by Type (2018-2029)
9.1.2 Asia Biologic Drugs Revenue by Type (2018-2029)
9.2 Asia Biologic Drugs Market Size by Application
9.2.1 Asia Biologic Drugs Sales by Application (2018-2029)
9.2.2 Asia Biologic Drugs Revenue by Application (2018-2029)
9.3 Asia Biologic Drugs Sales by Region
9.3.1 Asia Biologic Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biologic Drugs Revenue by Region (2018-2029)
9.3.3 Asia Biologic Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biologic Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Biologic Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biologic Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biologic Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Biologic Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biologic Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biologic Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Biologic Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biologic Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biologic Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Roche Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Abbott Laboratories Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Johnson & Johnson Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Company Information
11.4.2 Merck & Co. Overview
11.4.3 Merck & Co. Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Merck & Co. Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck & Co. Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Pfizer Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Overview
11.6.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amgen Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Sanofi Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Overview
11.8.3 Novartis Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Novartis Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Eli Lilly Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Overview
11.10.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biologic Drugs Industry Chain Analysis
12.2 Biologic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biologic Drugs Production Mode & Process
12.4 Biologic Drugs Sales and Marketing
12.4.1 Biologic Drugs Sales Channels
12.4.2 Biologic Drugs Distributors
12.5 Biologic Drugs Customers
13 Market Dynamics
13.1 Biologic Drugs Industry Trends
13.2 Biologic Drugs Market Drivers
13.3 Biologic Drugs Market Challenges
13.4 Biologic Drugs Market Restraints
14 Key Findings in The Global Biologic Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Biologic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Humira
Table 3. Major Manufacturers of Remicade
Table 4. Major Manufacturers of Rituxan
Table 5. Major Manufacturers of Enbrel
Table 6. Major Manufacturers of Lantus
Table 7. Major Manufacturers of Avastin
Table 8. Major Manufacturers of Herceptin
Table 9. Major Manufacturers of Others
Table 10. Global Biologic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Biologic Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Biologic Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 13. Global Biologic Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 14. Global Biologic Drugs Revenue Market Share by Region (2018-2024)
Table 15. Global Biologic Drugs Revenue Market Share by Region (2024-2029)
Table 16. Global Biologic Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 17. Global Biologic Drugs Sales by Region (2018-2024) & (K Units)
Table 18. Global Biologic Drugs Sales by Region (2024-2029) & (K Units)
Table 19. Global Biologic Drugs Sales Market Share by Region (2018-2024)
Table 20. Global Biologic Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Biologic Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 22. Global Biologic Drugs Sales Share by Manufacturers (2018-2024)
Table 23. Global Biologic Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 24. Global Biologic Drugs Revenue Share by Manufacturers (2018-2024)
Table 25. Global Key Players of Biologic Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 26. Biologic Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 27. Global Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Biologic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Drugs as of 2022)
Table 29. Global Key Manufacturers of Biologic Drugs, Manufacturing Base Distribution and Headquarters
Table 30. Global Key Manufacturers of Biologic Drugs, Product Offered and Application
Table 31. Global Key Manufacturers of Biologic Drugs, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Biologic Drugs Sales by Type (2018-2024) & (K Units)
Table 34. Global Biologic Drugs Sales by Type (2024-2029) & (K Units)
Table 35. Global Biologic Drugs Sales Share by Type (2018-2024)
Table 36. Global Biologic Drugs Sales Share by Type (2024-2029)
Table 37. Global Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 38. Global Biologic Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 39. Global Biologic Drugs Revenue Share by Type (2018-2024)
Table 40. Global Biologic Drugs Revenue Share by Type (2024-2029)
Table 41. Biologic Drugs Price by Type (2018-2024) & (USD/Unit)
Table 42. Global Biologic Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 43. Global Biologic Drugs Sales by Application (2018-2024) & (K Units)
Table 44. Global Biologic Drugs Sales by Application (2024-2029) & (K Units)
Table 45. Global Biologic Drugs Sales Share by Application (2018-2024)
Table 46. Global Biologic Drugs Sales Share by Application (2024-2029)
Table 47. Global Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 48. Global Biologic Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 49. Global Biologic Drugs Revenue Share by Application (2018-2024)
Table 50. Global Biologic Drugs Revenue Share by Application (2024-2029)
Table 51. Biologic Drugs Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Biologic Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 53. US & Canada Biologic Drugs Sales by Type (2018-2024) & (K Units)
Table 54. US & Canada Biologic Drugs Sales by Type (2024-2029) & (K Units)
Table 55. US & Canada Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 56. US & Canada Biologic Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 57. US & Canada Biologic Drugs Sales by Application (2018-2024) & (K Units)
Table 58. US & Canada Biologic Drugs Sales by Application (2024-2029) & (K Units)
Table 59. US & Canada Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 60. US & Canada Biologic Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 61. US & Canada Biologic Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 62. US & Canada Biologic Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 63. US & Canada Biologic Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 64. US & Canada Biologic Drugs Sales by Country (2018-2024) & (K Units)
Table 65. US & Canada Biologic Drugs Sales by Country (2024-2029) & (K Units)
Table 66. Europe Biologic Drugs Sales by Type (2018-2024) & (K Units)
Table 67. Europe Biologic Drugs Sales by Type (2024-2029) & (K Units)
Table 68. Europe Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Biologic Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 70. Europe Biologic Drugs Sales by Application (2018-2024) & (K Units)
Table 71. Europe Biologic Drugs Sales by Application (2024-2029) & (K Units)
Table 72. Europe Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Biologic Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 74. Europe Biologic Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 75. Europe Biologic Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Biologic Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 77. Europe Biologic Drugs Sales by Country (2018-2024) & (K Units)
Table 78. Europe Biologic Drugs Sales by Country (2024-2029) & (K Units)
Table 79. China Biologic Drugs Sales by Type (2018-2024) & (K Units)
Table 80. China Biologic Drugs Sales by Type (2024-2029) & (K Units)
Table 81. China Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Biologic Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 83. China Biologic Drugs Sales by Application (2018-2024) & (K Units)
Table 84. China Biologic Drugs Sales by Application (2024-2029) & (K Units)
Table 85. China Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Biologic Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 87. Asia Biologic Drugs Sales by Type (2018-2024) & (K Units)
Table 88. Asia Biologic Drugs Sales by Type (2024-2029) & (K Units)
Table 89. Asia Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 90. Asia Biologic Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 91. Asia Biologic Drugs Sales by Application (2018-2024) & (K Units)
Table 92. Asia Biologic Drugs Sales by Application (2024-2029) & (K Units)
Table 93. Asia Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 94. Asia Biologic Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 95. Asia Biologic Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Asia Biologic Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 97. Asia Biologic Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 98. Asia Biologic Drugs Sales by Region (2018-2024) & (K Units)
Table 99. Asia Biologic Drugs Sales by Region (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Biologic Drugs Sales by Type (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Biologic Drugs Sales by Type (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Biologic Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Biologic Drugs Sales by Application (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Biologic Drugs Sales by Application (2024-2029) & (K Units)
Table 106. Middle East, Africa and Latin America Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Biologic Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Biologic Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 109. Middle East, Africa and Latin America Biologic Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Biologic Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 111. Middle East, Africa and Latin America Biologic Drugs Sales by Country (2018-2024) & (K Units)
Table 112. Middle East, Africa and Latin America Biologic Drugs Sales by Country (2024-2029) & (K Units)
Table 113. Roche Company Information
Table 114. Roche Description and Major Businesses
Table 115. Roche Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Roche Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Roche Recent Developments
Table 118. Abbott Laboratories Company Information
Table 119. Abbott Laboratories Description and Major Businesses
Table 120. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Abbott Laboratories Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Abbott Laboratories Recent Developments
Table 123. Johnson & Johnson Company Information
Table 124. Johnson & Johnson Description and Major Businesses
Table 125. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Johnson & Johnson Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Johnson & Johnson Recent Developments
Table 128. Merck & Co. Company Information
Table 129. Merck & Co. Description and Major Businesses
Table 130. Merck & Co. Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Merck & Co. Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Merck & Co. Recent Developments
Table 133. Pfizer Company Information
Table 134. Pfizer Description and Major Businesses
Table 135. Pfizer Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Pfizer Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Pfizer Recent Developments
Table 138. Amgen Company Information
Table 139. Amgen Description and Major Businesses
Table 140. Amgen Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Amgen Recent Developments
Table 143. Sanofi Company Information
Table 144. Sanofi Description and Major Businesses
Table 145. Sanofi Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Sanofi Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Sanofi Recent Developments
Table 148. Novartis Company Information
Table 149. Novartis Description and Major Businesses
Table 150. Novartis Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Novartis Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Novartis Recent Developments
Table 153. Eli Lilly Company Information
Table 154. Eli Lilly Description and Major Businesses
Table 155. Eli Lilly Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Eli Lilly Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Eli Lilly Recent Developments
Table 158. Amgen Company Information
Table 159. Amgen Description and Major Businesses
Table 160. Amgen Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Amgen Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Biologic Drugs Distributors List
Table 166. Biologic Drugs Customers List
Table 167. Biologic Drugs Market Trends
Table 168. Biologic Drugs Market Drivers
Table 169. Biologic Drugs Market Challenges
Table 170. Biologic Drugs Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Drugs Product Picture
Figure 2. Global Biologic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biologic Drugs Market Share by Type in 2022 & 2029
Figure 4. Humira Product Picture
Figure 5. Remicade Product Picture
Figure 6. Rituxan Product Picture
Figure 7. Enbrel Product Picture
Figure 8. Lantus Product Picture
Figure 9. Avastin Product Picture
Figure 10. Herceptin Product Picture
Figure 11. Others Product Picture
Figure 12. Global Biologic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 13. Global Biologic Drugs Market Share by Application in 2022 & 2029
Figure 14. Diabetes
Figure 15. Inflammation
Figure 16. Auto-Immune Diseases
Figure 17. Blood Diseases
Figure 18. Cardiovascular Diseases
Figure 19. Others
Figure 20. Biologic Drugs Report Years Considered
Figure 21. Global Biologic Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 22. Global Biologic Drugs Revenue 2018-2029 (US$ Million)
Figure 23. Global Biologic Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 24. Global Biologic Drugs Revenue Market Share by Region (2018-2029)
Figure 25. Global Biologic Drugs Sales 2018-2029 ((K Units)
Figure 26. Global Biologic Drugs Sales Market Share by Region (2018-2029)
Figure 27. US & Canada Biologic Drugs Sales YoY (2018-2029) & (K Units)
Figure 28. US & Canada Biologic Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Europe Biologic Drugs Sales YoY (2018-2029) & (K Units)
Figure 30. Europe Biologic Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 31. China Biologic Drugs Sales YoY (2018-2029) & (K Units)
Figure 32. China Biologic Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 33. Asia (excluding China) Biologic Drugs Sales YoY (2018-2029) & (K Units)
Figure 34. Asia (excluding China) Biologic Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 35. Middle East, Africa and Latin America Biologic Drugs Sales YoY (2018-2029) & (K Units)
Figure 36. Middle East, Africa and Latin America Biologic Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 37. The Biologic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 38. The Top 5 and 10 Largest Manufacturers of Biologic Drugs in the World: Market Share by Biologic Drugs Revenue in 2022
Figure 39. Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 40. Global Biologic Drugs Sales Market Share by Type (2018-2029)
Figure 41. Global Biologic Drugs Revenue Market Share by Type (2018-2029)
Figure 42. Global Biologic Drugs Sales Market Share by Application (2018-2029)
Figure 43. Global Biologic Drugs Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Biologic Drugs Sales Market Share by Type (2018-2029)
Figure 45. US & Canada Biologic Drugs Revenue Market Share by Type (2018-2029)
Figure 46. US & Canada Biologic Drugs Sales Market Share by Application (2018-2029)
Figure 47. US & Canada Biologic Drugs Revenue Market Share by Application (2018-2029)
Figure 48. US & Canada Biologic Drugs Revenue Share by Country (2018-2029)
Figure 49. US & Canada Biologic Drugs Sales Share by Country (2018-2029)
Figure 50. U.S. Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. Canada Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. Europe Biologic Drugs Sales Market Share by Type (2018-2029)
Figure 53. Europe Biologic Drugs Revenue Market Share by Type (2018-2029)
Figure 54. Europe Biologic Drugs Sales Market Share by Application (2018-2029)
Figure 55. Europe Biologic Drugs Revenue Market Share by Application (2018-2029)
Figure 56. Europe Biologic Drugs Revenue Share by Country (2018-2029)
Figure 57. Europe Biologic Drugs Sales Share by Country (2018-2029)
Figure 58. Germany Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 59. France Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 60. U.K. Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 61. Italy Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 62. Russia Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 63. China Biologic Drugs Sales Market Share by Type (2018-2029)
Figure 64. China Biologic Drugs Revenue Market Share by Type (2018-2029)
Figure 65. China Biologic Drugs Sales Market Share by Application (2018-2029)
Figure 66. China Biologic Drugs Revenue Market Share by Application (2018-2029)
Figure 67. Asia Biologic Drugs Sales Market Share by Type (2018-2029)
Figure 68. Asia Biologic Drugs Revenue Market Share by Type (2018-2029)
Figure 69. Asia Biologic Drugs Sales Market Share by Application (2018-2029)
Figure 70. Asia Biologic Drugs Revenue Market Share by Application (2018-2029)
Figure 71. Asia Biologic Drugs Revenue Share by Region (2018-2029)
Figure 72. Asia Biologic Drugs Sales Share by Region (2018-2029)
Figure 73. Japan Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 74. South Korea Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 75. China Taiwan Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 76. Southeast Asia Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. India Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Biologic Drugs Sales Market Share by Type (2018-2029)
Figure 79. Middle East, Africa and Latin America Biologic Drugs Revenue Market Share by Type (2018-2029)
Figure 80. Middle East, Africa and Latin America Biologic Drugs Sales Market Share by Application (2018-2029)
Figure 81. Middle East, Africa and Latin America Biologic Drugs Revenue Market Share by Application (2018-2029)
Figure 82. Middle East, Africa and Latin America Biologic Drugs Revenue Share by Country (2018-2029)
Figure 83. Middle East, Africa and Latin America Biologic Drugs Sales Share by Country (2018-2029)
Figure 84. Brazil Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 85. Mexico Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 86. Turkey Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 87. Israel Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 88. GCC Countries Biologic Drugs Revenue (2018-2029) & (US$ Million)
Figure 89. Biologic Drugs Value Chain
Figure 90. Biologic Drugs Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries